Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Capital Expenditures (2016 - 2022)

Historic Capital Expenditures for Nephros (NEPH) over the last 6 years, with Q2 2022 value amounting to $103000.0.

  • Nephros' Capital Expenditures changed N/A to $103000.0 in Q2 2022 from the same period last year, while for Sep 2024 it was $103000.0, marking a year-over-year change of. This contributed to the annual value of $55000.0 for FY2024, which is 2666.67% down from last year.
  • Latest data reveals that Nephros reported Capital Expenditures of $103000.0 as of Q2 2022.
  • In the past 5 years, Nephros' Capital Expenditures ranged from a high of $103000.0 in Q2 2022 and a low of $13000.0 during Q3 2020
  • In the last 3 years, Nephros' Capital Expenditures had a median value of $23000.0 in 2021 and averaged $37200.0.
  • Its Capital Expenditures has fluctuated over the past 5 years, first changed by 0.0% in 2021, then skyrocketed by 4782.61% in 2022.
  • Quarter analysis of 3 years shows Nephros' Capital Expenditures stood at $13000.0 in 2020, then changed by 0.0% to $13000.0 in 2021, then surged by 692.31% to $103000.0 in 2022.
  • Its last three reported values are $103000.0 in Q2 2022, $34000.0 for Q1 2022, and $13000.0 during Q3 2021.